This inventor holds 1 USPTO granted patent. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2024
Title: Oleg Igorevich Smotrov: Innovator in Medical Antibody Development.
Introduction
Oleg Igorevich Smotrov is a notable inventor based in Ramon', Russia. He has made significant contributions to the field of medicine, particularly in the development of antibodies that target specific human receptors. His work addresses critical health issues and aims to improve treatment options for various diseases.
Latest Patents
Oleg Smotrov holds a patent for an "Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6." This invention is crucial as it provides alternative antibodies or fragments that can specifically bind to the human interleukin-6 receptor. The potential applications of this invention include its use as a drug for treating or diagnosing diseases related to interleukin-6, as well as alleviating symptoms associated with these conditions. He has 1 patent to his name.
Career Highlights
Throughout his career, Oleg Smotrov has focused on innovative solutions in the medical field. His research has contributed to a better understanding of interleukin-6 and its role in various diseases. This focus on targeted therapies showcases his commitment to advancing medical science and improving patient outcomes.
Collaborations
Oleg has collaborated with several professionals in his field, including Aleksei Aleksandrovich Aleksandrov and Aleksandr Aleksandrovich Moshchenko. These collaborations have enhanced the scope and impact of his research, leading to more comprehensive solutions in antibody development.
Conclusion
Oleg Igorevich Smotrov is a pioneering inventor whose work in antibody development has the potential to transform medical treatments. His innovative approach to addressing health challenges highlights the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile